The haptoglobin (Hp) 2 allele correlates with greater histologic and biological improvement in nonalcoholic steatohepatitis (NASH) with vitamin E treatment as compared with the Hp 1 allele, a study has shown.
Inflammatory bowel disease (IBD) contributes to an increased risk of developing chronic kidney disease, with the risk highest for younger patients, as shown in a study. Meanwhile, the use of IBD medications does not offer a protective benefit.
Patients undergoing neurogastroenterology examinations commonly present with symptoms of avoidant/restrictive food intake disorder (ARFID) driven mostly by fear of gastrointestinal symptoms, as shown in a recent study.
In patients with Lynch syndrome, chromoendoscopy (ChE) allows for the detection of more lesions than white light endoscopy (WLE), especially in terms of adenomas, flat lesions and proximal lesions, reports a recent meta-analysis.
Exposure to corticosteroids in patients with autoimmune hepatitis (AIH) appears to contribute to increased risks of cataract, diabetes and bone fractures, a study has found. Notably, the fracture risk is elevated at low doses, while the risk of adverse events overall is dose-dependent and is reversible.
Supplementation with oral nano vitamin D appears to moderate disease activity and severity grade of patients with active ulcerative colitis (UC), suggests a study, adding that this association is more evident in those achieving a target vitamin D level of 40 ng/mL.
Discontinuation of antitumour necrosis factor (anti-TNF) therapy for perianal Crohn’s disease is highly likely to lead to relapse, with some patients even requiring defunctioning surgery, according to a study conducted across Asia.
The trend in liver disease-related mortality in individuals with HIV has changed, with a reduction in the incidence of viral hepatitis-related deaths and an increase in non-alcoholic fatty liver disease (NAFLD)-related deaths, according to a study presented at the International Liver Congress™ (ILC 2019).